Ergonovine-induced esophageal spasm in patients with chest pain resembling angina pectoris.
We studied the effect of ergonovine maleate (EM) on esophageal motor activity in 18 consecutive patients with angina-like chest pain. Significant coronary artery disease was excluded in each patient by cardiac catheterization studies. Baseline esophageal motility was abnormal in 12 patients (66%). After injection of EM, ten patients developed their typical chest pain at the onset of repetitive contractions. Thus, chest pain and esophageal dysfunction were clearly linked. Compared with saline injection, only the repetitive contractions were significantly increased after AM in these patients (P less than 0.01). Amplitude and duration of contractions were increased after EM, but not significantly. Due to potentially serious adverse effects, however, EM cannot be recommended for routine use as a provocative agent.
D000328:Adult; D000368:Aged; D000787:Angina Pectoris / Q000503:physiopathology; D003937:Diagnosis, Differential; D004874:Ergonovine / Q000031:analogs & derivatives*; D004935:Esophageal Diseases / Q000175:diagnosis* / Q000503:physiopathology; D004947:Esophagus / Q000187:drug effects; D006801:Humans; D008297:Male; D008365:Manometry; D008875:Middle Aged; D010146:Pain / Q000175:diagnosis* / Q000503:physiopathology; D013035:Spasm / Q000175:diagnosis / Q000503:physiopathology; D013909:Thorax
D004874:Ergonovine